Skip to main content

Cholinergic agonists inhibit HMGB1 release and improve survival in sepsis.

Publication ,  Conference
Czura, CJ; Liao, H; Ochani, M; Tracey, KJ; Ulloa, L
Published in: SHOCK
January 1, 2005

Published In

SHOCK

ISSN

1073-2322

Publication Date

January 1, 2005

Volume

23

Start / End Page

80 / 80

Location

Vienna, AUSTRIA

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Conference Name

11th Congress of the European-Shock-Society

Related Subject Headings

  • Emergency & Critical Care Medicine
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Czura, C. J., Liao, H., Ochani, M., Tracey, K. J., & Ulloa, L. (2005). Cholinergic agonists inhibit HMGB1 release and improve survival in sepsis. In SHOCK (Vol. 23, pp. 80–80). Vienna, AUSTRIA: LIPPINCOTT WILLIAMS & WILKINS.
Czura, C. J., H. Liao, M. Ochani, K. J. Tracey, and L. Ulloa. “Cholinergic agonists inhibit HMGB1 release and improve survival in sepsis.” In SHOCK, 23:80–80. LIPPINCOTT WILLIAMS & WILKINS, 2005.
Czura CJ, Liao H, Ochani M, Tracey KJ, Ulloa L. Cholinergic agonists inhibit HMGB1 release and improve survival in sepsis. In: SHOCK. LIPPINCOTT WILLIAMS & WILKINS; 2005. p. 80–80.
Czura, C. J., et al. “Cholinergic agonists inhibit HMGB1 release and improve survival in sepsis.SHOCK, vol. 23, LIPPINCOTT WILLIAMS & WILKINS, 2005, pp. 80–80.
Czura CJ, Liao H, Ochani M, Tracey KJ, Ulloa L. Cholinergic agonists inhibit HMGB1 release and improve survival in sepsis. SHOCK. LIPPINCOTT WILLIAMS & WILKINS; 2005. p. 80–80.

Published In

SHOCK

ISSN

1073-2322

Publication Date

January 1, 2005

Volume

23

Start / End Page

80 / 80

Location

Vienna, AUSTRIA

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Conference Name

11th Congress of the European-Shock-Society

Related Subject Headings

  • Emergency & Critical Care Medicine
  • 3202 Clinical sciences
  • 1103 Clinical Sciences